These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18251960)

  • 1. Vancomycin use in patients requiring hemodialysis: a literature review.
    Pallotta KE; Manley HJ
    Semin Dial; 2008; 21(1):63-70. PubMed ID: 18251960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
    McDonald LC; Hageman JC
    Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Dutch MRSA policy should be retained].
    Vlaminckx BJ; Troelstra A; van der Bruggen T
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus.
    Tacconelli E; Cataldo MA; Albanese A; Tumbarello M; Arduini E; Spanu T; Fadda G; Anile C; Maira G; Federico G; Cauda R
    J Hosp Infect; 2008 Aug; 69(4):337-44. PubMed ID: 18602187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units.
    Humphreys H; Smyth EG
    J Hosp Infect; 2005 Mar; 59(3):259-61; author reply 263-6. PubMed ID: 15694985
    [No Abstract]   [Full Text] [Related]  

  • 6. Limitations of vancomycin in the management of resistant staphylococcal infections.
    Kollef MH
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of severe infections caused by Staphylococcus aureus: a change in the vancomycin paradigm?
    Aranha Camargo LF
    Shock; 2008 Oct; 30 Suppl 1():67-9. PubMed ID: 18704006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of prophylactic vancomycin to prevent MRSA colonization: does this double-edged sword promote future vancomycin resistance or is it a safe preventative strategy that should be used in all patients in the context of MRSA endemicity?
    Li Bassi G; Saucedo LM
    Minerva Anestesiol; 2010 Mar; 76(3):175-7. PubMed ID: 20203543
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.
    Scheetz MH; Wunderink RG; Postelnick MJ; Noskin GA
    Pharmacotherapy; 2006 Apr; 26(4):539-50. PubMed ID: 16553514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: how valid are international comparisons of success?
    Humphreys H
    J Hosp Infect; 2006 Feb; 62(2):133-5. PubMed ID: 16337032
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Rubinstein E; Kollef MH; Nathwani D
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S378-85. PubMed ID: 18462093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Estes L; Orenstem R
    Clin Ther; 2007 Apr; 29(4):759-60; author reply 760-1. PubMed ID: 17617300
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of vancomycin use in chronic haemodialysis patients: room for improvement.
    Zvonar R; Natarajan S; Edwards C; Roth V
    Nephrol Dial Transplant; 2008 Nov; 23(11):3690-5. PubMed ID: 18565979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The killer bug.
    Shnayerson M
    Fortune; 2002 Sep; 146(6):149-50, 152, 154 passim. PubMed ID: 12360834
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternative agents for the treatment of invasive infections due to methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin.
    Tattevin P; Arvieux C; Michelet C
    Arch Intern Med; 2007 Jun; 167(11):1206; author reply 1208-9. PubMed ID: 17563033
    [No Abstract]   [Full Text] [Related]  

  • 19. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Deresinski S
    Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin: does it still have a role as an antistaphylococcal agent?
    Deresinski S
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):393-401. PubMed ID: 17547504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.